Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Expression of p16 protein in gallbladder carcinoma and its precancerous conditions.

Choi HJ, Yun SS, Kim HJ, Choi JH.

Hepatogastroenterology. 2010 Jan-Feb;57(97):18-21.

PMID:
20422865
2.

Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.

Quan ZW, Wu K, Wang J, Shi W, Zhang Z, Merrell RC.

J Am Coll Surg. 2001 Oct;193(4):380-3.

PMID:
11584965
4.
5.

Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.

Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani P.

Mod Pathol. 2003 Apr;16(4):299-308.

6.

Mutation and altered expression of beta-catenin during gallbladder carcinogenesis.

Chang HJ, Jee CD, Kim WH.

Am J Surg Pathol. 2002 Jun;26(6):758-66.

PMID:
12023580
7.

Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.

Kim HS, Kim GY, Lim SJ, Park YK, Kim YW.

Hum Pathol. 2010 Nov;41(11):1609-16. doi: 10.1016/j.humpath.2010.04.012. Epub 2010 Aug 4.

PMID:
20688353
8.

Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.

Xiong L, Yang Z, Yang L, Liu J, Miao X.

J Surg Oncol. 2012 Jan;105(1):97-103. doi: 10.1002/jso.22055. Epub 2011 Aug 3.

PMID:
21815153
9.

Genetic alterations in gallbladder adenoma, dysplasia and carcinoma.

Kim YT, Kim J, Jang YH, Lee WJ, Ryu JK, Park YK, Kim SW, Kim WH, Yoon YB, Kim CY.

Cancer Lett. 2001 Aug 10;169(1):59-68.

PMID:
11410326
10.

Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder.

Lynch BC, Lathrop SL, Ye D, Ma TY, Cerilli LA.

Ann Diagn Pathol. 2008 Jun;12(3):161-4. doi: 10.1016/j.anndiagpath.2007.06.003. Epub 2007 Oct 24.

PMID:
18486890
11.

Expression of the GLUT1 glucose transporter in gallbladder carcinomas.

Kim YW, Park YK, Yoon TY, Lee SM.

Hepatogastroenterology. 2002 Jul-Aug;49(46):907-11.

PMID:
12143238
12.

p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.

Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J.

Hum Pathol. 1996 Apr;27(4):360-5.

PMID:
8617479
13.

The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.

da Rocha AO, Coutinho LM, Scholl JG, Leboutte LD.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1310-4.

PMID:
15362740
14.
15.

[Neoplasms and dysplasias of the gallbladder and their relationship with lithiasis. A case-control clinicopathological study].

Martínez-Guzmán G, de la Rosa-Bayón J.

Rev Gastroenterol Mex. 1998 Apr-Jun;63(2):82-8. Spanish.

PMID:
10068733
16.

Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.

Xiong L, Deng X, Wen Y, Yang Z, Miao X.

World J Surg Oncol. 2013 Mar 26;11:80. doi: 10.1186/1477-7819-11-80.

17.

p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions.

Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimori T, Maeda S, Saitoh Y.

Hepatogastroenterology. 1996 May-Jun;43(9):521-6.

PMID:
8799388
18.

Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.

Roa JC, Roa I, Correa P, Vo Q, Araya JC, Villaseca M, Guzmán P, Schneider BG.

J Gastroenterol. 2005 Jan;40(1):79-86.

PMID:
15692793
19.

Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.

Hughes NR, Bhathal PS.

J Clin Pathol. 2013 Mar;66(3):212-7. doi: 10.1136/jclinpath-2012-201146. Epub 2012 Dec 25.

PMID:
23268317
20.

Supplemental Content

Support Center